Whittier Trust Co. of Nevada Inc. Raises Stock Position in Doximity, Inc. $DOCS

Whittier Trust Co. of Nevada Inc. grew its position in Doximity, Inc. (NYSE:DOCS) by 32,406.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 97,843 shares of the company’s stock after purchasing an additional 97,542 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Doximity were worth $2,256,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOCS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after acquiring an additional 210 shares during the last quarter. BOKF NA increased its stake in Doximity by 5.3% during the third quarter. BOKF NA now owns 5,356 shares of the company’s stock worth $392,000 after acquiring an additional 269 shares during the last quarter. Northwestern Mutual Investment Management Company LLC increased its stake in Doximity by 1.1% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 30,736 shares of the company’s stock worth $1,361,000 after acquiring an additional 333 shares during the last quarter. Lifestyle Asset Management Inc. grew its holdings in shares of Doximity by 5.9% during the 4th quarter. Lifestyle Asset Management Inc. now owns 7,083 shares of the company’s stock worth $314,000 after purchasing an additional 396 shares during the period. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in shares of Doximity by 99.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after purchasing an additional 397 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Transactions at Doximity

In other news, insider Siddharth Sitaram sold 2,444 shares of the business’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the transaction, the insider directly owned 90,706 shares of the company’s stock, valued at approximately $1,851,309.46. The trade was a 2.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director owned 19,839 shares in the company, valued at $517,004.34. The trade was a 31.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 16,180 shares of company stock worth $395,110 in the last ninety days. 31.30% of the stock is owned by corporate insiders.

Doximity Trading Up 0.4%

NYSE:DOCS traded up $0.08 during midday trading on Tuesday, reaching $22.94. The company had a trading volume of 510,151 shares, compared to its average volume of 3,792,135. Doximity, Inc. has a 12-month low of $17.15 and a 12-month high of $76.51. The firm has a market capitalization of $4.20 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 6.79 and a beta of 1.30. The stock’s fifty day simple moving average is $21.62 and its 200-day simple moving average is $28.09.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on DOCS. Royal Bank Of Canada reiterated an “outperform” rating and set a $44.00 price target on shares of Doximity in a research report on Monday, March 9th. Zacks Research cut shares of Doximity from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 2nd. BTIG Research downgraded shares of Doximity from a “buy” rating to a “neutral” rating in a report on Thursday, May 14th. Barclays reissued an “equal weight” rating and issued a $20.00 target price (down from $38.00) on shares of Doximity in a research report on Thursday, May 14th. Finally, Truist Financial restated a “hold” rating and set a $19.00 price target (down from $29.00) on shares of Doximity in a research note on Thursday, May 14th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, Doximity has a consensus rating of “Hold” and a consensus price target of $29.33.

Doximity Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.